The 10th edition of the Vibrant Gujarat Global Summit concluded with MoUs for 41,299 projects worth Rs 26.33 lakh crore, making it a massive success.

The 10th Vibrant Gujarat Global Summit saw 1.3 lakh participants from 140 countries, discussing global priorities and concerns. 35 countries partnered, with MoUs signed in sustainability, green...

Gujarat Chief Minister Bhupendra Patel leads Vibrant Gujarat Roadshow in Tokyo, promoting the upcoming Vibrant Gujarat Global Summit in January 2024. The event saw participation from over 200...

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...